Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MTRI
$18.79
+2.37%
MTRI
· InMed Pharmaceuticals Inc.
$18.79
+0.44 (+2.37%)
At close · Nov 13
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Going-concern doubt
— flagged Nov 3, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued.”View the 10-Q filed Nov 3, 2026
Market Cap
$8.58M
Shares
549,374
Volume · Nov 13
7703
Avg daily vol (6 sessions)
62.9K
All webcasts
Earnings call · FY2021 Q1
InMed Pharmaceuticals Inc. (MTRI) Q1 2021 Earnings Call
Net income
-$1.60M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 13, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Dec 17, 2020 · complete as-filed document